Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lonza
Pharma
Roche-Innovent, AstraZeneca, Viatris and more—Fierce Pharma Asia
Roche and Ideaya separately licensed ADCs from Chinese firms. Experts weighed in on AZ's China probes. A Viatris plant got a warning letter. And more.
Angus Liu
Jan 3, 2025 8:37am
Lonza aims to shed capsules business, restructure CDMO offerings
Dec 12, 2024 8:58am
Swiss CDMO Lonza widens its ADC digs with 2028 expansion
Nov 12, 2024 10:00am
AGC Bio embarks on turnaround strategy under new CEO
Nov 7, 2024 10:10am
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Headhunter lays out leadership goals for CDMO industry
Aug 14, 2024 10:51am
